To further reveal the clinical significance of FBI-1/HIF-1α axis in HCC, the correlation between FBI-1 and HIF-1α with the prognosis of HCC patients who received the molecular targeted agent Sorafenib was shown. Here, HIF1A is linked to hepatocellular carcinoma.